Global Antibody Based Therapeutics Market Research Report 2023

Antibody Based Therapeutics Market

Therapeutic antibodies are drugs that use antibodies, one of the main players in our immune system inherent in our body. By making use of the specificity by which each antibody recognizes only one antigen, pinpointed attacks on specific antigens are possible.

The Therapeutic Antibodies Drug Market is driven by the remarkable potential of therapeutic antibodies to treat a diverse array of diseases, from cancer and autoimmune disorders to infectious diseases. Monoclonal antibodies have gained prominence as highly targeted and effective therapeutic agents that can modulate the immune system, neutralize pathogens, and inhibit disease-associated proteins. As precision medicine and biopharmaceutical innovations continue to advance, the demand for therapeutic antibodies grows. Innovations in antibody design, engineering, and manufacturing technologies further contribute to market expansion. Nevertheless, a significant challenge for this market is the need to address high production costs, optimize therapeutic antibody development processes, and navigate complex regulatory pathways while ensuring accessibility and affordability for patients. Overcoming manufacturing complexities, managing research and development costs, and addressing regulatory standards are ongoing challenges. Additionally, the market faces competition from small molecules and other biologic therapies, necessitating continuous research and development efforts to unlock the full therapeutic potential of therapeutic antibodies. Striking a balance between providing safe, effective, and accessible therapeutic antibody drugs while addressing scientific and regulatory challenges is essential for the continued growth of the Therapeutic Antibodies Drug Market.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Antibody Based Therapeutics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of Antibody Based Therapeutics Market Report

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Antibody Based Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Monoclonal Antibodies

1.2.3 Bi-Specific Antibodies Therapy

1.2.4 Antibody-drug Conjugates

1.2.5 Other

1.3 Market by Application

1.3.1 Global Antibody Based Therapeutics Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Immune Diseases

1.3.3 Cancer

1.3.4 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Antibody Based Therapeutics Market Perspective (2018-2029)

2.2 Antibody Based Therapeutics Growth Trends by Region

2.2.1 Global Antibody Based Therapeutics Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Antibody Based Therapeutics Historic Market Size by Region (2018-2023)

2.2.3 Antibody Based Therapeutics Forecasted Market Size by Region (2024-2029)

2.3 Antibody Based Therapeutics Market Dynamics

2.3.1 Antibody Based Therapeutics Industry Trends

2.3.2 Antibody Based Therapeutics Market Drivers

2.3.3 Antibody Based Therapeutics Market Challenges

2.3.4 Antibody Based Therapeutics Market Restraints

3.1 Global Top Antibody Based Therapeutics Players by Revenue

3.1.1 Global Top Antibody Based Therapeutics Players by Revenue (2018-2023)

3.1.2 Global Antibody Based Therapeutics Revenue Market Share by Players (2018-2023)

3.2 Global Antibody Based Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Antibody Based Therapeutics Revenue

3.4 Global Antibody Based Therapeutics Market Concentration Ratio

3.4.1 Global Antibody Based Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Antibody Based Therapeutics Revenue in 2022

3.5 Antibody Based Therapeutics Key Players Head office and Area Served

3.6 Key Players Antibody Based Therapeutics Product Solution and Service

3.7 Date of Enter into Antibody Based Therapeutics Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Antibody Based Therapeutics Historic Market Size by Type (2018-2023)

4.2 Global Antibody Based Therapeutics Forecasted Market Size by Type (2024-2029)

5.1 Global Antibody Based Therapeutics Historic Market Size by Application (2018-2023)

5.2 Global Antibody Based Therapeutics Forecasted Market Size by Application (2024-2029)

6.1 North America Antibody Based Therapeutics Market Size (2018-2029)

6.2 North America Antibody Based Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Antibody Based Therapeutics Market Size by Country (2018-2023)

6.4 North America Antibody Based Therapeutics Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Antibody Based Therapeutics Market Size (2018-2029)

7.2 Europe Antibody Based Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Antibody Based Therapeutics Market Size by Country (2018-2023)

7.4 Europe Antibody Based Therapeutics Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Antibody Based Therapeutics Market Size (2018-2029)

8.2 Asia-Pacific Antibody Based Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Antibody Based Therapeutics Market Size by Region (2018-2023)

8.4 Asia-Pacific Antibody Based Therapeutics Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Antibody Based Therapeutics Market Size (2018-2029)

9.2 Latin America Antibody Based Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Antibody Based Therapeutics Market Size by Country (2018-2023)

9.4 Latin America Antibody Based Therapeutics Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Antibody Based Therapeutics Market Size (2018-2029)

10.2 Middle East & Africa Antibody Based Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Antibody Based Therapeutics Market Size by Country (2018-2023)

10.4 Middle East & Africa Antibody Based Therapeutics Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 AbbVie

11.1.1 AbbVie Company Detail

11.1.2 AbbVie Business Overview

11.1.3 AbbVie Antibody Based Therapeutics Introduction

11.1.4 AbbVie Revenue in Antibody Based Therapeutics Business (2018-2023)

11.1.5 AbbVie Recent Development

11.2 Johnson & Johnson

11.2.1 Johnson & Johnson Company Detail

11.2.2 Johnson & Johnson Business Overview

11.2.3 Johnson & Johnson Antibody Based Therapeutics Introduction

11.2.4 Johnson & Johnson Revenue in Antibody Based Therapeutics Business (2018-2023)

11.2.5 Johnson & Johnson Recent Development

11.3 Novartis

11.3.1 Novartis Company Detail

11.3.2 Novartis Business Overview

11.3.3 Novartis Antibody Based Therapeutics Introduction

11.3.4 Novartis Revenue in Antibody Based Therapeutics Business (2018-2023)

11.3.5 Novartis Recent Development

11.4 Gilead Sciences

11.4.1 Gilead Sciences Company Detail

11.4.2 Gilead Sciences Business Overview

11.4.3 Gilead Sciences Antibody Based Therapeutics Introduction

11.4.4 Gilead Sciences Revenue in Antibody Based Therapeutics Business (2018-2023)

11.4.5 Gilead Sciences Recent Development

11.5 Roche

11.5.1 Roche Company Detail

11.5.2 Roche Business Overview

11.5.3 Roche Antibody Based Therapeutics Introduction

11.5.4 Roche Revenue in Antibody Based Therapeutics Business (2018-2023)

11.5.5 Roche Recent Development

11.6 Bristol-Myers Squibb

11.6.1 Bristol-Myers Squibb Company Detail

11.6.2 Bristol-Myers Squibb Business Overview

11.6.3 Bristol-Myers Squibb Antibody Based Therapeutics Introduction

11.6.4 Bristol-Myers Squibb Revenue in Antibody Based Therapeutics Business (2018-2023)

11.6.5 Bristol-Myers Squibb Recent Development

11.7 Amgen

11.7.1 Amgen Company Detail

11.7.2 Amgen Business Overview

11.7.3 Amgen Antibody Based Therapeutics Introduction

11.7.4 Amgen Revenue in Antibody Based Therapeutics Business (2018-2023)

11.7.5 Amgen Recent Development

11.8 AstraZeneca

11.8.1 AstraZeneca Company Detail

11.8.2 AstraZeneca Business Overview

11.8.3 AstraZeneca Antibody Based Therapeutics Introduction

11.8.4 AstraZeneca Revenue in Antibody Based Therapeutics Business (2018-2023)

11.8.5 AstraZeneca Recent Development

11.9 Merck & Co

11.9.1 Merck & Co Company Detail

11.9.2 Merck & Co Business Overview

11.9.3 Merck & Co Antibody Based Therapeutics Introduction

11.9.4 Merck & Co Revenue in Antibody Based Therapeutics Business (2018-2023)

11.9.5 Merck & Co Recent Development

11.10 Takeda

11.10.1 Takeda Company Detail

11.10.2 Takeda Business Overview

11.10.3 Takeda Antibody Based Therapeutics Introduction

11.10.4 Takeda Revenue in Antibody Based Therapeutics Business (2018-2023)

11.10.5 Takeda Recent Development

11.11 Merck KGaA

11.11.1 Merck KGaA Company Detail

11.11.2 Merck KGaA Business Overview

11.11.3 Merck KGaA Antibody Based Therapeutics Introduction

11.11.4 Merck KGaA Revenue in Antibody Based Therapeutics Business (2018-2023)

11.11.5 Merck KGaA Recent Development

11.12 Seagen

11.12.1 Seagen Company Detail

11.12.2 Seagen Business Overview

11.12.3 Seagen Antibody Based Therapeutics Introduction

11.12.4 Seagen Revenue in Antibody Based Therapeutics Business (2018-2023)

11.12.5 Seagen Recent Development

11.13 Eli Lilly

11.13.1 Eli Lilly Company Detail

11.13.2 Eli Lilly Business Overview

11.13.3 Eli Lilly Antibody Based Therapeutics Introduction

11.13.4 Eli Lilly Revenue in Antibody Based Therapeutics Business (2018-2023)

11.13.5 Eli Lilly Recent Development

11.14 Ono Pharmaceutical

11.14.1 Ono Pharmaceutical Company Detail

11.14.2 Ono Pharmaceutical Business Overview

11.14.3 Ono Pharmaceutical Antibody Based Therapeutics Introduction

11.14.4 Ono Pharmaceutical Revenue in Antibody Based Therapeutics Business (2018-2023)

11.14.5 Ono Pharmaceutical Recent Development

11.15 Pfizer

11.15.1 Pfizer Company Detail

11.15.2 Pfizer Business Overview

11.15.3 Pfizer Antibody Based Therapeutics Introduction

11.15.4 Pfizer Revenue in Antibody Based Therapeutics Business (2018-2023)

11.15.5 Pfizer Recent Development

11.16 Regeneron

11.16.1 Regeneron Company Detail

11.16.2 Regeneron Business Overview

11.16.3 Regeneron Antibody Based Therapeutics Introduction

11.16.4 Regeneron Revenue in Antibody Based Therapeutics Business (2018-2023)

11.16.5 Regeneron Recent Development

11.17 Innovent

11.17.1 Innovent Company Detail

11.17.2 Innovent Business Overview

11.17.3 Innovent Antibody Based Therapeutics Introduction

11.17.4 Innovent Revenue in Antibody Based Therapeutics Business (2018-2023)

11.17.5 Innovent Recent Development

11.18 Hengrui Medicine

11.18.1 Hengrui Medicine Company Detail

11.18.2 Hengrui Medicine Business Overview

11.18.3 Hengrui Medicine Antibody Based Therapeutics Introduction

11.18.4 Hengrui Medicine Revenue in Antibody Based Therapeutics Business (2018-2023)

11.18.5 Hengrui Medicine Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Antibody Based Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Monoclonal Antibodies

    Table 3. Key Players of Bi-Specific Antibodies Therapy

    Table 4. Key Players of Antibody-drug Conjugates

    Table 5. Key Players of Other

    Table 6. Global Antibody Based Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Antibody Based Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 8. Global Antibody Based Therapeutics Market Size by Region (2018-2023) & (US$ Million)

    Table 9. Global Antibody Based Therapeutics Market Share by Region (2018-2023)

    Table 10. Global Antibody Based Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 11. Global Antibody Based Therapeutics Market Share by Region (2024-2029)

    Table 12. Antibody Based Therapeutics Market Trends

    Table 13. Antibody Based Therapeutics Market Drivers

    Table 14. Antibody Based Therapeutics Market Challenges

    Table 15. Antibody Based Therapeutics Market Restraints

    Table 16. Global Antibody Based Therapeutics Revenue by Players (2018-2023) & (US$ Million)

    Table 17. Global Antibody Based Therapeutics Market Share by Players (2018-2023)

    Table 18. Global Top Antibody Based Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Based Therapeutics as of 2022)

    Table 19. Ranking of Global Top Antibody Based Therapeutics Companies by Revenue (US$ Million) in 2022

    Table 20. Global 5 Largest Players Market Share by Antibody Based Therapeutics Revenue (CR5 and HHI) & (2018-2023)

    Table 21. Key Players Headquarters and Area Served

    Table 22. Key Players Antibody Based Therapeutics Product Solution and Service

    Table 23. Date of Enter into Antibody Based Therapeutics Market

    Table 24. Mergers & Acquisitions, Expansion Plans

    Table 25. Global Antibody Based Therapeutics Market Size by Type (2018-2023) & (US$ Million)

    Table 26. Global Antibody Based Therapeutics Revenue Market Share by Type (2018-2023)

    Table 27. Global Antibody Based Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 28. Global Antibody Based Therapeutics Revenue Market Share by Type (2024-2029)

    Table 29. Global Antibody Based Therapeutics Market Size by Application (2018-2023) & (US$ Million)

    Table 30. Global Antibody Based Therapeutics Revenue Market Share by Application (2018-2023)

    Table 31. Global Antibody Based Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 32. Global Antibody Based Therapeutics Revenue Market Share by Application (2024-2029)

    Table 33. North America Antibody Based Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 34. North America Antibody Based Therapeutics Market Size by Country (2018-2023) & (US$ Million)

    Table 35. North America Antibody Based Therapeutics Market Size by Country (2024-2029) & (US$ Million)

    Table 36. Europe Antibody Based Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 37. Europe Antibody Based Therapeutics Market Size by Country (2018-2023) & (US$ Million)

    Table 38. Europe Antibody Based Therapeutics Market Size by Country (2024-2029) & (US$ Million)

    Table 39. Asia-Pacific Antibody Based Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 40. Asia-Pacific Antibody Based Therapeutics Market Size by Region (2018-2023) & (US$ Million)

    Table 41. Asia-Pacific Antibody Based Therapeutics Market Size by Region (2024-2029) & (US$ Million)

    Table 42. Latin America Antibody Based Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 43. Latin America Antibody Based Therapeutics Market Size by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Antibody Based Therapeutics Market Size by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Antibody Based Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 46. Middle East & Africa Antibody Based Therapeutics Market Size by Country (2018-2023) & (US$ Million)

    Table 47. Middle East & Africa Antibody Based Therapeutics Market Size by Country (2024-2029) & (US$ Million)

    Table 48. AbbVie Company Detail

    Table 49. AbbVie Business Overview

    Table 50. AbbVie Antibody Based Therapeutics Product

    Table 51. AbbVie Revenue in Antibody Based Therapeutics Business (2018-2023) & (US$ Million)

    Table 52. AbbVie Recent Development

    Table 53. Johnson & Johnson Company Detail

    Table 54. Johnson & Johnson Business Overview

    Table 55. Johnson & Johnson Antibody Based Therapeutics Product

    Table 56. Johnson & Johnson Revenue in Antibody Based Therapeutics Business (2018-2023) & (US$ Million)

    Table 57. Johnson & Johnson Recent Development

    Table 58. Novartis Company Detail

    Table 59. Novartis Business Overview

    Table 60. Novartis Antibody Based Therapeutics Product

    Table 61. Novartis Revenue in Antibody Based Therapeutics Business (2018-2023) & (US$ Million)

    Table 62. Novartis Recent Development

    Table 63. Gilead Sciences Company Detail

    Table 64. Gilead Sciences Business Overview

    Table 65. Gilead Sciences Antibody Based Therapeutics Product

    Table 66. Gilead Sciences Revenue in Antibody Based Therapeutics Business (2018-2023) & (US$ Million)

    Table 67. Gilead Sciences Recent Development

    Table 68. Roche Company Detail

    Table 69. Roche Business Overview

    Table 70. Roche Antibody Based Therapeutics Product

    Table 71. Roche Revenue in Antibody Based Therapeutics Business (2018-2023) & (US$ Million)

    Table 72. Roche Recent Development

    Table 73. Bristol-Myers Squibb Company Detail

    Table 74. Bristol-Myers Squibb Business Overview

    Table 75. Bristol-Myers Squibb Antibody Based Therapeutics Product

    Table 76. Bristol-Myers Squibb Revenue in Antibody Based Therapeutics Business (2018-2023) & (US$ Million)

    Table 77. Bristol-Myers Squibb Recent Development

    Table 78. Amgen Company Detail

    Table 79. Amgen Business Overview

    Table 80. Amgen Antibody Based Therapeutics Product

    Table 81. Amgen Revenue in Antibody Based Therapeutics Business (2018-2023) & (US$ Million)

    Table 82. Amgen Recent Development

    Table 83. AstraZeneca Company Detail

    Table 84. AstraZeneca Business Overview

    Table 85. AstraZeneca Antibody Based Therapeutics Product

    Table 86. AstraZeneca Revenue in Antibody Based Therapeutics Business (2018-2023) & (US$ Million)

    Table 87. AstraZeneca Recent Development

    Table 88. Merck & Co Company Detail

    Table 89. Merck & Co Business Overview

    Table 90. Merck & Co Antibody Based Therapeutics Product

    Table 91. Merck & Co Revenue in Antibody Based Therapeutics Business (2018-2023) & (US$ Million)

    Table 92. Merck & Co Recent Development

    Table 93. Takeda Company Detail

    Table 94. Takeda Business Overview

    Table 95. Takeda Antibody Based Therapeutics Product

    Table 96. Takeda Revenue in Antibody Based Therapeutics Business (2018-2023) & (US$ Million)

    Table 97. Takeda Recent Development

    Table 98. Merck KGaA Company Detail

    Table 99. Merck KGaA Business Overview

    Table 100. Merck KGaA Antibody Based Therapeutics Product

    Table 101. Merck KGaA Revenue in Antibody Based Therapeutics Business (2018-2023) & (US$ Million)

    Table 102. Merck KGaA Recent Development

    Table 103. Seagen Company Detail

    Table 104. Seagen Business Overview

    Table 105. Seagen Antibody Based Therapeutics Product

    Table 106. Seagen Revenue in Antibody Based Therapeutics Business (2018-2023) & (US$ Million)

    Table 107. Seagen Recent Development

    Table 108. Eli Lilly Company Detail

    Table 109. Eli Lilly Business Overview

    Table 110. Eli Lilly Antibody Based Therapeutics Product

    Table 111. Eli Lilly Revenue in Antibody Based Therapeutics Business (2018-2023) & (US$ Million)

    Table 112. Eli Lilly Recent Development

    Table 113. Ono Pharmaceutical Company Detail

    Table 114. Ono Pharmaceutical Business Overview

    Table 115. Ono Pharmaceutical Antibody Based Therapeutics Product

    Table 116. Ono Pharmaceutical Revenue in Antibody Based Therapeutics Business (2018-2023) & (US$ Million)

    Table 117. Ono Pharmaceutical Recent Development

    Table 118. Pfizer Company Detail

    Table 119. Pfizer Business Overview

    Table 120. Pfizer Antibody Based Therapeutics Product

    Table 121. Pfizer Revenue in Antibody Based Therapeutics Business (2018-2023) & (US$ Million)

    Table 122. Pfizer Recent Development

    Table 123. Regeneron Company Detail

    Table 124. Regeneron Business Overview

    Table 125. Regeneron Antibody Based Therapeutics Product

    Table 126. Regeneron Revenue in Antibody Based Therapeutics Business (2018-2023) & (US$ Million)

    Table 127. Regeneron Recent Development

    Table 128. Innovent Company Detail

    Table 129. Innovent Business Overview

    Table 130. Innovent Antibody Based Therapeutics Product

    Table 131. Innovent Revenue in Antibody Based Therapeutics Business (2018-2023) & (US$ Million)

    Table 132. Innovent Recent Development

    Table 133. Hengrui Medicine Company Detail

    Table 134. Hengrui Medicine Business Overview

    Table 135. Hengrui Medicine Antibody Based Therapeutics Product

    Table 136. Hengrui Medicine Revenue in Antibody Based Therapeutics Business (2018-2023) & (US$ Million)

    Table 137. Hengrui Medicine Recent Development

    Table 138. Research Programs/Design for This Report

    Table 139. Key Data Information from Secondary Sources

    Table 140. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Antibody Based Therapeutics Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Antibody Based Therapeutics Market Share by Type: 2022 VS 2029

    Figure 3. Monoclonal Antibodies Features

    Figure 4. Bi-Specific Antibodies Therapy Features

    Figure 5. Antibody-drug Conjugates Features

    Figure 6. Other Features

    Figure 7. Global Antibody Based Therapeutics Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 8. Global Antibody Based Therapeutics Market Share by Application: 2022 VS 2029

    Figure 9. Immune Diseases Case Studies

    Figure 10. Cancer Case Studies

    Figure 11. Other Case Studies

    Figure 12. Antibody Based Therapeutics Report Years Considered

    Figure 13. Global Antibody Based Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 14. Global Antibody Based Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 15. Global Antibody Based Therapeutics Market Share by Region: 2022 VS 2029

    Figure 16. Global Antibody Based Therapeutics Market Share by Players in 2022

    Figure 17. Global Top Antibody Based Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Based Therapeutics as of 2022)

    Figure 18. The Top 10 and 5 Players Market Share by Antibody Based Therapeutics Revenue in 2022

    Figure 19. North America Antibody Based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 20. North America Antibody Based Therapeutics Market Share by Country (2018-2029)

    Figure 21. United States Antibody Based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Canada Antibody Based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Europe Antibody Based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Europe Antibody Based Therapeutics Market Share by Country (2018-2029)

    Figure 25. Germany Antibody Based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. France Antibody Based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. U.K. Antibody Based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Italy Antibody Based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Russia Antibody Based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Nordic Countries Antibody Based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Asia-Pacific Antibody Based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Asia-Pacific Antibody Based Therapeutics Market Share by Region (2018-2029)

    Figure 33. China Antibody Based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Japan Antibody Based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. South Korea Antibody Based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Southeast Asia Antibody Based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. India Antibody Based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Australia Antibody Based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Latin America Antibody Based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Latin America Antibody Based Therapeutics Market Share by Country (2018-2029)

    Figure 41. Mexico Antibody Based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Brazil Antibody Based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Middle East & Africa Antibody Based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Middle East & Africa Antibody Based Therapeutics Market Share by Country (2018-2029)

    Figure 45. Turkey Antibody Based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Saudi Arabia Antibody Based Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. AbbVie Revenue Growth Rate in Antibody Based Therapeutics Business (2018-2023)

    Figure 48. Johnson & Johnson Revenue Growth Rate in Antibody Based Therapeutics Business (2018-2023)

    Figure 49. Novartis Revenue Growth Rate in Antibody Based Therapeutics Business (2018-2023)

    Figure 50. Gilead Sciences Revenue Growth Rate in Antibody Based Therapeutics Business (2018-2023)

    Figure 51. Roche Revenue Growth Rate in Antibody Based Therapeutics Business (2018-2023)

    Figure 52. Bristol-Myers Squibb Revenue Growth Rate in Antibody Based Therapeutics Business (2018-2023)

    Figure 53. Amgen Revenue Growth Rate in Antibody Based Therapeutics Business (2018-2023)

    Figure 54. AstraZeneca Revenue Growth Rate in Antibody Based Therapeutics Business (2018-2023)

    Figure 55. Merck & Co Revenue Growth Rate in Antibody Based Therapeutics Business (2018-2023)

    Figure 56. Takeda Revenue Growth Rate in Antibody Based Therapeutics Business (2018-2023)

    Figure 57. Merck KGaA Revenue Growth Rate in Antibody Based Therapeutics Business (2018-2023)

    Figure 58. Seagen Revenue Growth Rate in Antibody Based Therapeutics Business (2018-2023)

    Figure 59. Eli Lilly Revenue Growth Rate in Antibody Based Therapeutics Business (2018-2023)

    Figure 60. Ono Pharmaceutical Revenue Growth Rate in Antibody Based Therapeutics Business (2018-2023)

    Figure 61. Pfizer Revenue Growth Rate in Antibody Based Therapeutics Business (2018-2023)

    Figure 62. Regeneron Revenue Growth Rate in Antibody Based Therapeutics Business (2018-2023)

    Figure 63. Innovent Revenue Growth Rate in Antibody Based Therapeutics Business (2018-2023)

    Figure 64. Hengrui Medicine Revenue Growth Rate in Antibody Based Therapeutics Business (2018-2023)

    Figure 65. Bottom-up and Top-down Approaches for This Report

    Figure 66. Data Triangulation

    Figure 67. Key Executives Interviewed